First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that causes the damage to the myelin sheath as well as axonal degeneration. Individuals with MS appear to have changes in the numbers and functions of T-cell subsets, leading to an immunological i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Wakiro, Noto, Daisuke, Araki, Manabu, Okamoto, Tomoko, Lin, Youwei, Yamaguchi, Hiromi, Kadowaki-Saga, Ryoko, Kimura, Atsuko, Kimura, Yukio, Sato, Noriko, Ishizuka, Takami, Nakamura, Harumasa, Miyake, Sachiko, Yamamura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041592/
https://www.ncbi.nlm.nih.gov/pubmed/36993937
http://dx.doi.org/10.1177/17562864231162153

Ejemplares similares

Ejemplares similares